News & Policy

NY Post article today on peptides

Holy Smokes! Prescription only??

Glutathione supplementation and cancer concerns

We got a media mole

FDA cracks down on ‘misleading’ compounded GLP-1s by telehealth companies

New quintuple agonist from Eli Lilly! So new it is not yet named.

Article on the slowdown.

Eli Lilly's Latest Scheme

Is it legal? UK

503(b) Compounding Pharmacy Ceasing Production of GLP-1s after FDA Letter

Psychedelic Drugs like ibogaine compounds To Become Legal

Great new article about GLP-1 in NY Times about their various uses and the science around GLP-1s

Eli Lilly’s new medication for alcoholism?

NYT article about a telehealth provider

Andrew Huberman Slams ‘Peptides’ Media Coverage as a “Dog’s Breakfast,” Says Pharma Divide Fuels Black and Gray Markets

New GLP-1 pill approval sparks talk on access, side effects, and daily vs weekly use

Retatrutide brand name ideas?

Reta Passes Another Trial

Proper refillable insulin pen

MAHA peptide push?

New higher doses of semaglutide receives FDA approval

Podcast Guest Highlights Pharma Lobbying on Peptides Despite Acquisition Deal

Weight regain after stopping GLP's

Need help with recommendations for my father in law

Novo Nordisk strikes deal for Hims to sell Wegovy and Ozempic, drops lawsuit

Can Ozempic cure Addiction?

Affordable weight loss medication production and US patent issues

FDA Warns 30 Telehealth Companies Against Illegal Marketing of Compounded GLP-1s

Biomedind (quadruple) Even Better Answer to Novo Nordisk's Answer to Retatrutide.? NA-931

Novo Nordisk’s experimental obesity drug, CagriSema, failed to outperform Eli Lilly’s Zepbound in a head-to-head, phase 3 trial